Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Alprostadil is the active ingredient of these drugs:
Austria
Austria
Australia Austria Brazil Canada Cyprus
France Tunisia United States
Austria
Austria Canada Ireland Lithuania Netherlands
Austria
Austria Brazil
Canada Hong Kong Netherlands Singapore United Kingdom
France
Lithuania
United Kingdom
Spain
Austria Cyprus France Ireland Netherlands
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):